Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation disorders in liver disease.

Lucio Amitrano1, Maria A Guardascione, Vincenzo Brancaccio

  • 1Gastroenterology Unit, A. Cardarelli Hospital, Via Morghen 92, 80129 Naples, Italy. luamitra@tin.it

Seminars in Liver Disease
|April 3, 2002
PubMed
Summary

Liver disease disrupts blood clotting, increasing bleeding risks. This review covers causes, complications like sepsis, and treatments for coagulation disorders in liver patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aza[7]helicene Diimide: Backbone-Controlled Excited-State Charge Transfer and Electronic Coupling.

Organic letters·2026
Same author

Through-bond <i>versus</i> through-space conjugation and high-dissymmetry chiroptical switching in proton-responsive [8]helicene bisbenzimidazoles.

Journal of materials chemistry. C·2026
Same author

Multidetector computed tomography angiography in non-variceal upper gastrointestinal bleeding: when, why and how?

Expert review of gastroenterology & hepatology·2025
Same author

Hip Fracture as a Systemic Disease in Older Adults: A Narrative Review on Multisystem Implications and Management.

Medical sciences (Basel, Switzerland)·2025
Same author

Spring-Like Behavior in [8]Helicene Diimides: How Helical Pitch Governs Optical Anisotropy and Electronic Conjugation.

Angewandte Chemie (International ed. in English)·2025
Same author

Ultra-Narrowband Circularly Polarized Luminescence from Multiple 1,4-Azaborine-Embedded Helical Nanographenes.

Journal of the American Chemical Society·2024

Area of Science:

  • Hepatology
  • Hematology
  • Internal Medicine

Background:

  • The liver is crucial for synthesizing clotting factors and regulating hemostasis.
  • Liver diseases frequently lead to complex coagulation disorders.
  • These disorders increase bleeding risks during medical procedures.

Purpose of the Study:

  • To review the multifaceted causes of coagulation disorders in liver disease.
  • To discuss the clinical implications, including bleeding and thrombosis risks.
  • To outline current therapeutic strategies for managing these hemostatic abnormalities.

Main Methods:

  • Literature review of studies on liver disease and coagulation.
  • Analysis of etiological factors contributing to hemostatic dysfunction.

Related Experiment Videos

  • Synthesis of information on clinical manifestations and treatment approaches.

    • Main Results:

    • Liver disease causes coagulopathy through impaired factor synthesis, clearance issues, platelet dysfunction, and hyperfibrinolysis.
    • Patients face heightened bleeding risks, particularly during invasive procedures.
    • Specific conditions like acute fatty liver of pregnancy and liver transplantation present unique coagulation challenges.
    • Sepsis exacerbates hemostasis problems in cirrhotic patients with variceal bleeding.
    • Thrombotic events, though less common, primarily affect portal and mesenteric veins.

    Conclusions:

    • Coagulation disorders are a significant complication of liver disease, impacting patient outcomes.
    • Understanding the diverse causes is key to managing bleeding and thrombotic risks.
    • Tailored therapeutic interventions are essential for optimizing hemostasis in this patient population.